RINDI, Guido
 Distribuzione geografica
Continente #
NA - Nord America 2.424
EU - Europa 1.904
AS - Asia 697
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
SA - Sud America 1
Totale 5.034
Nazione #
US - Stati Uniti d'America 2.349
CN - Cina 595
UA - Ucraina 459
IE - Irlanda 444
SE - Svezia 347
FI - Finlandia 304
DE - Germania 204
CA - Canada 73
GB - Regno Unito 66
TR - Turchia 53
IT - Italia 47
IN - India 34
BE - Belgio 15
EU - Europa 7
FR - Francia 7
SG - Singapore 7
CZ - Repubblica Ceca 3
JP - Giappone 3
MX - Messico 2
RU - Federazione Russa 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
Totale 5.034
Città #
Chandler 464
Jacksonville 451
Dublin 443
Dearborn 244
Beijing 184
Ashburn 122
Nanjing 121
Princeton 100
San Mateo 97
Ann Arbor 78
Toronto 64
Wilmington 62
Izmir 50
Helsinki 42
Boardman 36
Nanchang 32
Hebei 30
Pune 30
Kunming 28
Shenyang 26
Jinan 24
Woodbridge 20
Hefei 18
New York 18
Tianjin 17
Los Angeles 16
Brussels 15
Changsha 14
Jiaxing 11
Norwalk 11
Shanghai 11
Guangzhou 9
Hangzhou 9
Borås 8
Des Moines 8
Parma 8
Zhengzhou 8
Auburn Hills 7
Bremen 7
Fremont 7
Taiyuan 6
London 5
Rockville 5
Seattle 5
Fuzhou 4
Grafing 4
Haikou 4
Ningbo 4
Baotou 3
Bologna 3
Kocaeli 3
Kyiv 3
New Orleans 3
Ottawa 3
Rio Saliceto 3
Wenzhou 3
Augusta 2
Carate Brianza 2
Changchun 2
Chengdu 2
Dong Ket 2
Düsseldorf 2
Guwahati 2
Lanzhou 2
Mola Di Bari 2
Montréal 2
Paris 2
Quzhou 2
Selvazzano Dentro 2
Singapore 2
Stockholm 2
Taizhou 2
Wuhan 2
Xian 2
Andover 1
Ardabil 1
Avoca 1
Bari 1
Bethany 1
Brampton 1
Brno 1
Budapest 1
Chicago 1
Chongqing 1
Clarks Summit 1
Columbus 1
Delhi 1
Edinburgh 1
Finchley 1
Garza García 1
Geelong 1
Geislingen an der Steige 1
Guadalajara 1
Gubbio 1
Huizen 1
Indianapolis 1
Jinhua 1
Langfang 1
Las Vegas 1
Lima 1
Totale 3.073
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 104
Xq25 and Xq26 identify the common minimal deletion region in malignant gastroenteropancreatic endocrine carcinomas 93
The assessment of malignancy in endocrine tumours of the gastrointestinal tract 90
A high resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications 84
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 82
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 76
Endocrine tumors of the gastrointestinal system 73
A randomised, double-blind, trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over five years 71
GHRELIN PROTECTS AGAINST ETHANOL-INDUCED GASTRIC ULCERS IN RATS: STUDIES ON THE MECHANISMS OF ACTION 69
Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors 68
Ghrelin expression and actions. A novel peptide for an old cell type of the diffuse endocrine system 66
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 66
Unusual case of giant typical carcinoid tumor 65
Optimisation of isolation of richly pure and homogenous primary human colonic smooth muscle cells 64
Etiology, molecular pathogenesis and genetics 63
Criteria for malignancy in gastrointestinal endocrine tumors 62
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor deficient mice. 61
Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer 59
Linee guida e criteri diagnostici minimi per la diagnosi istologica dei tumori endocrini del tratto gastroenteropancreatico 58
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS -2- WELL-DIFFERENTIATED DUODENAL TUMOR/CARCINOMA (EXCLUDING GASTRINOMAS). 58
Consensus guidelines for the management of patients with digestive neuroendocrine tumors -4- well-differentiated pancreatic tumor/carcinoma: insulinoma. 58
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 58
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. 57
Consensus guidelines for the management of patients with digestive neuroendocrine tumors: the second event and some final considerations 57
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 56
Classification of the neuroendocrine phenotype in cancer 56
The phenotype of gut endocrine tumors 56
PYY-Tag transgenic mice displaying abnormal (H(+)-K(+)ATPase activity and gastric mucosal barrier impairment 55
Biological and molecular aspects of gastroenteropancreatic endocrine tumors. 55
Primary mixed adenocarcinoma and small cell carcinoma of the appendix. A clinicopathologic, immunohistochemical and molecular study of a hitherto unreported tumor 54
CONSENSUS GUIDELINES ON THE MANAGEMENT OF PATIENTS WITH DIGESTIVE NEUROENDOCRINE TUMORS: WHY SUCH GUIDELINES AND HOW WE WENT ABOUT IT. 54
Three different synchronous unilateral lung cancers: a case report 54
Ghrelin in gastroenteric pathophysiology 53
Characterisation of gastric ghrelin cells in man and other mammals – Studies in adult and foetal tissues 53
Autoimmune gastritis 53
Anatomia patologica e tumori rari 53
Molecular aspects of the endocrine tumors of the pancreas and the gastrointestinal tract 53
Epidemiology of carcinoid neoplasm in Vaud, Switzerland, 1974-1997 53
Central Ghrelin gastroprotection involves nitric oxide/prostaglandins cross-talk. 53
GI Tract, General Pathology of Endocrine Growths 52
Unusual prostatic carcinoma with endocrine basophilic FSH-immunoreactive cells 52
Classification of neuroendocrine tumours. 52
Il pancreas endocrino. 51
Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract 51
Sudden onset of colitis after ablation of secretin-expressing lymphocytes in transgenic mice 50
Introduction to a revised clinicopathological classification of the neuroendocrine tumors of the gastroenteropancreatic tract 50
Peptide YY expression is an early event in intestinal endocrine cell differentiation: evidence from normal and transgenic mice. 50
Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. 50
Prognostic value of Goseki histological classification of adenocarcinoma of the cardia 50
Gastrinomas 49
Solitary microcarcinoid of the rectal stump in ulcerative colitis. Case report 49
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinico-pathologic study. 49
Transient developmental expression of secretin in serotoninergic neurons of mouse brain 48
Mismatch repair system (MMR) status correlates with response and survival in non small cell lung cancer (NSCLC) patients. 48
Endoscopic surgical treatment of pleomorphic adenoma of the inferior nasal turbinate. 48
Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases 48
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa 48
Highlights on biology of endocrine tumours of the gut and pancreas 47
Pathobiology and classification of digestive endocrine tumors 46
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non small cell lung cancer(NSCLC) and fine needle aspirates from distant metastatic sites. 46
Prognostic relevance of a novel TNM-classification system for gastroenteropancreatic neuroendocrine tumors of foregut origin 46
Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma 46
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system 45
The endocrine pancreas 45
Prognostic factors in gastrointestinal endocrine tumors 45
Targeted ablation of secretin cells reveals a close developmental relationship with CCK and L cells 45
The ontogeny and tissue specific regulation of ghrelin mRNA expression in the rat strongly indicate that ghrelin is primarily involved in the control of extraendocrine functions 44
CONSENSUS GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH DIGESTIVE ENDOCRINE TUMORS -1- WELL-DIFFERENTIATED GASTRIC TUMORS/CARCINOMAS. 44
Insulinoma 44
Gastric endocrine cells: types function and growth 44
Dilated intercellular spaces as marker of reflux disease: histology, semiquantitative score and morphometry at light microscopy 43
Is TCRg clonality assay useful to detect early celiac disease? 43
Effects of long-term esomeprazole treatment on the gastric mucosa 43
Endocrine tumours of the gut and pancreas tumor biology and classification 42
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. 42
Ghrelin expression in gut endocrine tumours 41
Gastroenteropancreatic neuroendocrine tumours. 41
Effect of CCK-B gastrin receptor blockade on chemically-induced colon carcinogenesis in mice: follow-up at 52 weeks 41
Évaluation de la malignité dans les tumeurs endocrines digestives: recommandations pratiques. 41
Pathology and biology of gastric neuroendocrine tumors in man 40
Vesicular monoamine transporter 2 as a marker of gastric ECL cell tumors 40
Endocrine and extraendocrine activity of ghrelin and the GHS: basic research 39
Origin and genetic background of insulinoma 38
Gastric neuroendocrine tumors - carcinoid and poorly differentiated carcinoma 37
The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumors: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. 37
Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours. 36
Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. 35
Development of neuroendocrine tumors in the gastro-intestinal tract of transgenic mice: heterogeneity of hormone expression. 35
A Refractory pleural small cell carcinoma in never smoker. A case report. 35
Enteroendocrine precursors differentiate independently of Wnt and form serotonin expressing adenomas in response to active ß-catenin. 34
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. 34
TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. 34
The normal endocrine cell of the gut. Changing concepts and new evidences 32
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 32
Morphological, molecular, and prognostic aspects of gastric endocrine tumors 31
Dilated intercellular spaces: a major morphological feature of esophagitis. 31
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells 29
Neuroendocrine tumors: history and histopathology 28
Histogenesis, diagnosis and molecular basis of the endocrine tumors of the digestive tract and pancreas 28
Pancreatic endocrine tumors 27
Totale 5.044
Categoria #
all - tutte 15.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201986 0 0 0 0 0 0 0 0 0 0 78 8
2019/20201.361 207 220 102 42 130 151 162 21 107 101 23 95
2020/2021649 11 97 101 5 89 6 97 0 117 10 110 6
2021/2022455 4 1 0 28 17 6 67 97 18 36 63 118
2022/20231.595 197 156 62 129 155 173 15 101 551 10 38 8
2023/2024348 20 71 9 15 41 141 12 16 6 14 3 0
Totale 5.044